TAXIS Pharmaceuticals' Unattributed - II Round

TAXIS Pharmaceuticals raised a round of funding on March 10, 2017.

TAXIS Pharmaceuticals is a privately held biopharmaceutical company dedicated to developing compounds to target the growing threat of antimicrobial resistance, including antibacterial and antiviral re…

Articles about TAXIS Pharmaceuticals' Unattributed - II Round: